Get started

Earnings

PNW - fall -104% to -13 cents per share on February 27The last earnings report on September 30 showed earnings per share of $3.5, beating the estimate of $3.4. P/B Ratio (1.254) is normal, around the industry mean (1.535). P/E Ratio (16.826) is within average values for comparable stocks, (21.523). Projected Growth (PEG Ratio) (2.254) is also within normal values, averaging (2.586). Dividend Yield (0.049) settles around the average of (0.051) among similar stocks. P/S Ratio (1.700) is also within normal values, averaging (3.327). With 1.84M shares outstanding, the current market capitalization sits at 7.99B.
NYSE:PNW
by tickeron
HSIC - fall -47% to 70 cents per share on February 27The last earnings report on September 30 showed earnings per share of $1.32, meeting the estimate of $1.32. P/B Ratio (2.843) is normal, around the industry mean (13.831). P/E Ratio (23.627) is within average values for comparable stocks, (27.428). Projected Growth (PEG Ratio) (1.888) is also within normal values, averaging (4.510). HSIC has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (0.837) is also within normal values, averaging (8.131). With 2.99M shares outstanding, the current market capitalization sits at 10.38B.
NASDAQ:HSIC
by tickeron
UHS - rise+13.33% to $2.89 per share on February 27The last earnings report on September 30 showed earnings per share of $2.55, beating the estimate of $2.37. P/B Ratio (1.849) is normal, around the industry mean (4.444). P/E Ratio (17.259) is within average values for comparable stocks, (74.151). UHS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.421). UHS has a moderately low Dividend Yield (0.005) as compared to the industry average of (0.023). P/S Ratio (0.831) is also within normal values, averaging (18.732). With 524.30K shares outstanding, the current market capitalization sits at 11.21B.
NYSE:UHS
by tickeron
Report earnings to fall -25% to 94 cents per share on February 2The last earnings report on September 30 showed earnings per share of $1.26, beating the estimate of $1.13. AMT's P/B Ratio (19.531) is slightly higher than the industry average of (2.290). P/E Ratio (126.620) is within average values for comparable stocks, (58.760). Projected Growth (PEG Ratio) (2.616) is also within normal values, averaging (7.055). Dividend Yield (0.034) settles around the average of (0.071) among similar stocks. P/S Ratio (8.019) is also within normal values, averaging (6.554). With 1.42M shares outstanding, the current market capitalization sits at 88.54B.
NYSE:AMT
by tickeron
EBAY is expected to report earnings to $1.03 per share on Feb 27The last earnings report on September 30 showed earnings per share of $1.03, beating the estimate of $1. P/B Ratio (3.871) is normal, around the industry mean (17.683). P/E Ratio (8.837) is within average values for comparable stocks, (77.417). Projected Growth (PEG Ratio) (3.347) is also within normal values, averaging (3.530). Dividend Yield (0.023) settles around the average of (0.032) among similar stocks. P/S Ratio (2.356) is also within normal values, averaging (4.177). With 7.12M shares outstanding, the current market capitalization sits at 22.84B.
NASDAQ:EBAY
by tickeron
LOW is expected to report earnings to fall -49% to $1.68 per shaThe last earnings report on October 31 showed earnings per share of $3.27, beating the estimate of $3.02. P/B Ratio (0.000) is normal, around the industry mean (8.869). P/E Ratio (17.834) is within average values for comparable stocks, (28.574). Projected Growth (PEG Ratio) (3.190) is also within normal values, averaging (2.899). Dividend Yield (0.019) settles around the average of (0.035) among similar stocks. P/S Ratio (1.524) is also within normal values, averaging (84.116). With 2.10M shares outstanding, the current market capitalization sits at 133.75B.
NYSE:LOW
by tickeron
RIVN guides itself lower- but is it a dip buy? SHORTRIVN spends more to produce of its nice truck than it sells them for. This is a recipe for a disaster which is now baking in the oven Earnings have plummeted. If guidance was better than realities forecast there might be a dip buy here. i have a variety of positions shorting RIVN when it runs a countertrend correction I will take a hedging long position until the correction is over. I use these shorts to balance my portfolio against risk from an overall falling market. Balanced in short vs long positions dollar for dollar and in the options balanced in expiration times spread across the next almost two years. I find this keeps the portfolio safe. I also look to LCID for a similar scenario while having a bullish bias on WKHS. NKLA is a whole 'nother story. SHORT RIVN do not dip buy . The chart is what you might expect. The disaster is what it is. This is basically a falling wedge and no where near impending a breakout upside.
NASDAQ:RIVNShort
by AwesomeAvani
Pespective for staking and earningFundamentally quite a strong project. As we can see, after the start the token did not go down, and is now in the accumulation stage. My idea is to hold a token, stake it on the platform, receive bonuses and allocations on launchpads. My main profit will come from this. When the project reaches the end of its cycle, sell the token unless the development team comes up with a better use. My goal for the token is $12.2 - $15.6. Entry price from current to 0.8$ Let's stake, take part in simple activities, and enjoy the profit
by snupy2312
AVGO Chipmaker in an ascending channel SHORTOn a 30-minute chart, like several other computer chip manufactures has approached or reached a near-term top. Overall Broadcom has gained 19% YTD. Earnings are in about two weeks. I see this as a short trade to follow AVGO from the top of the channel down to about 1225 in time to catch earnings at the bottom of the channel to end the swing trade and instead go long from there. I intend to close the trade two days before earnings and flip sides hunting the beat on the earnings.
NASDAQ:AVGOShort
by AwesomeAvani
LLY rides its success against obesity and diabetes LONGLLY shown on a daily chart has doubled in the past year with the introduction of new FDA approved drugs into the market. It has but out a series of favorable earnings reports with optimistic realistic guidance and glowing analysts' forecasts. It has done so without any volume pumps and just keeps grinding higher. This is because it is in the shadows of big technology stocks. Revenues consistently beat analysts' forecasts quarter after quarter. Institutions add small lots trying to preserve the price for future buys without any run-ups. I have done the same thing and I will continue to do so. While day trading biotechnology penny stocks, LLY along with UNH, PFE, and AZN is where the profits are parked for growth and compounding.
NYSE:LLYLong
by AwesomeAvani
1
LEARN THE MOST IMPORTANT FOREX FUNDAMENTALS 📰 Even though I am a pure technician and I rely only on technical analysis when I trade, we can not deny the fact that fundamentals are the main driver of the financial markets. In this post, we will discuss the most important fundamentals that affect forex market. You can check coming fundamental news on TradingView in the economic calendar. The calendar button on the right side will display the coming news. Click "only high importance" button and the system will display only the most important news. Here are the most important fundamental releases that you should pay close attention to: 📍Unemployment rate. Unemployment rate reflects the percentage of people without a job in a selected country or region. Rising unemployment rate usually signifies an unhealthy state of the economy and negatively affects the currency strength. 📍Housing prices. Housing prices reflect people's demand for housing. Rising rate reflects a healthy state of the economy, strengthening purchasing power of the individuals and their confidence in the future. Growing demand for housing is considered to be one of the most important drivers in the economy. 📍Inflation. Inflation reflects the purchasing power of a currency. It is usually measured by evaluation of the price of the selected basket of goods or services over some period. High inflation is usually the primary indicator of the weakness of the currency and the unhealthy state of the economy. 📍Monetary policy. Monetary policy is the actions of central banks related to money supply in the economy. There are two main levers: interests rates and bank reserve requirements. Higher interest rates suppress the economy, making the currency stronger. Lower interests rates increase the money supply, making the economy grow but devaluing the national currency. 📍Political discourse. Political discourse is the social, economical and geopolitical policies of the national government. Political ideology determines the set of priorities for the ruling party that directly impacts the state of the economy. 📍Payrolls and earnings. Payroll reports reflect the dynamic of the creation of new jobs by the economy, while average earnings show the increase or decrease of the earnings of the individuals. Growing earnings and payrolls positively affect the value of a national currency and signify the expansion of the economy. Pay closes attention to these fundamentals and monitor how the market reacts to that data. What fundamentals do you consider to be the most important? ❤️Please, support my work with like, thank you!❤️
FOREXCOM:XAUUSDEducation
by VasilyTrader
1
CVNA- consolidation after the earnings gap higher LONGCVA on the 30-minute chart shows a high tight flag pattern after the big report of profit on an annual report. Inflation is affecting auto stocks and recession is increasing the number of used care purchases while inflation hangs in there. URLs for both a description of the pattern and the news are embedded in the drawing. The RSI indicator shows a quick move of the faster RSI line over the slower RSI line. The pattern is typically said to forecast bullish continuation out of the consolidation. I will get shares at fair value in the consolidation and follow price for signs of that continuation. Another observation of the consolidation is the price getting above the third upper VWAP bandline then settling down onto the support of the first upper line. I look to target 78 from an entry of 68 for a 15-18% upside with risk constrained by the earnings report and current relative trading volume.
NYSE:CVNALong
by AwesomeAvani
Lucid Motors Faces Turbulence as Demand SlumpsLucid Motors ( NASDAQ:LCID ), backed by Saudi Arabia's investments, finds itself grappling with challenges as it slashes prices amid a slowdown in demand. The company's recent revenue report has raised eyebrows, indicating a bumpy road ahead. Amidst the swirling currents of the electric vehicle market, Lucid Motors ( NASDAQ:LCID ) stands as a beacon of ambition and innovation. However, recent developments suggest that even the most promising ventures can face turbulent waters. The Saudi Arabia-backed company, known for its cutting-edge Air sedans, has been forced to make tough decisions as demand softens and revenue falls short of expectations. Last week, Lucid Motors ( NASDAQ:LCID ) made headlines as it announced a significant price reduction for its Air sedans. This move was a strategic response to dwindling demand in an industry experiencing a noticeable slowdown. Despite initial excitement surrounding Lucid's ( NASDAQ:LCID ) sleek and high-performance vehicles, consumers seem to be hesitating amidst concerns over cost and market saturation. The decision to slash prices underscores the delicate balance Lucid Motors ( NASDAQ:LCID ) must strike between maintaining profitability and stimulating demand. In an increasingly competitive landscape, where legacy automakers and new startups alike vie for market share, pricing strategies can make or break a company's prospects. For Lucid ( NASDAQ:LCID ), the challenge lies in navigating this terrain while staying true to its vision of delivering premium electric vehicles that redefine the driving experience. However, pricing adjustments are just one piece of the puzzle. Lucid Motors ( NASDAQ:LCID ) recently released its fourth-quarter revenue report, and the numbers paint a sobering picture. Revenue came in at $157.2 million, falling short of analysts' expectations, which averaged $179.9 million according to LSEG data. This revenue miss underscores the broader challenges facing the company as it grapples with a slowdown in deliveries and consumer reluctance to commit amidst high costs. The discrepancy between projected and actual revenue highlights the unpredictable nature of the electric vehicle market. While Lucid Motors has made significant strides in technology and design, translating these advancements into sustained profitability remains a formidable task. The company's ability to ramp up production, streamline operations, and capture market share will be crucial in determining its long-term success. Despite these challenges, there are reasons for cautious optimism. Lucid Motors ( NASDAQ:LCID ) boasts a talented team of engineers and designers, a state-of-the-art manufacturing facility, and a strong financial backing from Saudi Arabia's sovereign wealth fund. Additionally, the company's recent entry into the public markets via a SPAC merger has provided it with the necessary capital to fuel its growth ambitions. Looking ahead, Lucid Motors ( NASDAQ:LCID ) must focus on executing its strategic vision while remaining agile in response to market dynamics. This will require a delicate balance of innovation, cost management, and customer engagement. As the electric vehicle market continues to evolve, Lucid Motors ( NASDAQ:LCID ) has the potential to emerge as a leading player. However, the road ahead is fraught with challenges, and success will ultimately hinge on its ability to navigate the currents of change with skill and determination.
NASDAQ:LCID
by DEXWireNews
Analyzing Goosehead's Fourth Quarter and Full Year 2023 ResultsGoosehead Insurance, Inc. (NASDAQ: NASDAQ:GSHD ) stands out as a beacon of growth and innovation. The company's recently announced fourth-quarter and full-year 2023 results underscore its remarkable trajectory and strategic prowess. Let's delve into the highlights of Goosehead's ( NASDAQ:GSHD ) performance and its promising outlook for 2024. Strong Performance Amidst Growth Initiatives: Goosehead's ( NASDAQ:GSHD ) fourth-quarter 2023 results paint a picture of resilience and expansion. With total revenues reaching $63.0 million, reflecting a robust 10% increase year-over-year, the company demonstrates its ability to capture market opportunities effectively. Core revenues, a key metric excluding certain elements, soared to $56.9 million, marking a parallel 10% growth over the previous year. Profitability Soars: One of the most striking aspects of Goosehead's ( NASDAQ:GSHD ) performance is its impressive profitability surge. Net income for the fourth quarter surged to $5.4 million, a remarkable improvement from $2.6 million in the same period last year. This surge translates to a staggering 650% increase in earnings per share (EPS), reaching $0.15 per share, and a 155% increase in adjusted EPS, standing at $0.28 per share. Such remarkable profitability growth is a testament to Goosehead's ( NASDAQ:GSHD ) efficient operational strategies and unwavering commitment to delivering value to shareholders. Strategic Initiatives Pay Off: The successful implementation of changes aimed at enhancing productivity and increasing earnings power has yielded tangible results. Notably, the reorganization of corporate sales leadership in late 2022 and the consolidation of franchise leadership with corporate in Q4 2023 have driven significant productivity gains. With a keen focus on accelerating new business production growth in 2024, particularly within its franchise network, Goosehead ( NASDAQ:GSHD ) is poised for even greater success in the years ahead. Outlook for 2024: Looking ahead, Goosehead's ( NASDAQ:GSHD ) guidance for the full year 2024 reflects a bullish sentiment and a robust growth trajectory. Total written premiums are expected to range between $3.70 billion and $3.85 billion, representing organic growth of 25% to 30%. Similarly, total revenues are anticipated to range between $310 million and $320 million, reflecting organic growth of 19% to 22%. With an expected expansion in adjusted EBITDA margin for the full year 2024, Goosehead ( NASDAQ:GSHD ) remains steadfast in its pursuit of sustainable growth and industry leadership. Conclusion: In conclusion, Goosehead ( NASDAQ:GSHD ) Insurance, Inc.'s stellar performance in the fourth quarter and full year 2023 underscores its resilience, strategic vision, and commitment to excellence. With a track record of strong growth and a promising outlook for 2024, Goosehead ( NASDAQ:GSHD ) continues to soar high in the competitive landscape of personal lines insurance. As the company continues to execute its strategic initiatives and capitalize on emerging opportunities, investors can remain confident in Goosehead's ( NASDAQ:GSHD ) ability to deliver long-term value and maintain its position as a leader in the industry.
NASDAQ:GSHD
by DEXWireNews
Moderna's Surprising Profit Signals Post-Pandemic PivotModerna ( NASDAQ:MRNA ), the pioneering vaccine maker, reported a surprise fourth-quarter profit, sending ripples of optimism through the market. Bolstered by unexpected revenue and strategic cost-cutting measures, the company's resilience amid shifting tides in the pharmaceutical landscape has drawn both attention and applause. Unveiling the Numbers: Moderna's ( NASDAQ:MRNA ) fourth-quarter profit stood at a commendable $217 million, or 55 cents a share, defying analyst expectations of a substantial loss. This unexpected triumph was fueled by a combination of factors, including unforeseen deferred revenue and a strategic overhaul in manufacturing operations. The company's ability to navigate challenges and adapt swiftly underscores its agility and forward-thinking approach. Navigating the COVID-19 Landscape: While Moderna's COVID-19 vaccine continues to be its flagship product, generating substantial revenue, the company is strategically diversifying its portfolio. Despite a decline in COVID vaccine sales from 2022 to 2023, Moderna ( NASDAQ:MRNA ) remains steadfast in its commitment to innovation. The imminent approval decision for its respiratory syncytial virus (RSV) shot marks a significant milestone in this diversification strategy, offering a glimpse into the company's post-pandemic roadmap. Looking Beyond COVID: Moderna's ( NASDAQ:MRNA ) ambitious roadmap extends far beyond the realm of COVID-19. With plans to launch its RSV shot in key markets and a robust pipeline of experimental shots targeting influenza, cancer, and cytomegalovirus, the company is poised for a transformative journey. Despite concerns over efficacy declines compared to rival offerings, Moderna's ( NASDAQ:MRNA ) unwavering focus on research and development signals a bold leap into uncharted territories. International Endeavors: Moderna's ( NASDAQ:MRNA ) participation in the EU Health Emergency and Response Authority’s tendering procedure underscores its commitment to global health initiatives. By prioritizing key international markets and aligning with strategic partners, the company aims to broaden its reach and impact. The forthcoming decision on the EU tender is poised to shape the company's trajectory in the global arena, setting the stage for future collaborations and expansions. Charting the Course Ahead: As Moderna ( NASDAQ:MRNA ) reaffirms its 2024 forecast amidst shifting market dynamics, the company remains steadfast in its pursuit of excellence. With a projected $4 billion in sales and a focus on operational execution, Moderna ( NASDAQ:MRNA ) is poised to navigate challenges and seize opportunities in the years ahead. Conclusion: Moderna's ( NASDAQ:MRNA ) unexpected profit surge and strategic roadmap offer a compelling narrative of resilience and innovation in a rapidly evolving landscape. With eyes set on new horizons and a steadfast resolve, Moderna ( NASDAQ:MRNA ) emerges as a beacon of hope in the post-pandemic world.
NASDAQ:MRNALong
by DEXWireNews
GRPN on a one month breakout LONGThis is to follow up my previous idea on Groupon. On the 2H chart, price is in a one month sustained breakout from the volume profile and into the upper VWAP band lines both anchored for end of 2023. The faster green RSI line crossed the 50 about the same time and basically has not looked down. The slower RSI line has slowly risen from 55 to 65. This is in the consumer discretionary sector and hot necessarily hinged to technology stocks. I see this as rock-solid as it gets. I will load more shares now and also load more ona dip There was a big earnings miss in November and then Goldman Sachs raised its target from 5 to 7.5 which seems like a big adjustment after an earnings miss. I suppose GS knows their stuff.
NASDAQ:GRPNLong
by AwesomeAvani